19 research outputs found

    Jargon alert: Pareto efficiency

    Get PDF
    Economics

    Special section : Base closures in the Fifth District

    Get PDF
    Federal Reserve District, 5th ; Job security

    Universities open doors : Gulf coast students migrate to Fifth District

    Get PDF
    Universities and colleges ; Federal Reserve District, 5th

    The Effects of Protein Kinase C Beta II Peptide Modulation on Superoxide Release in Rat Polymorphonuclear Leukocytes

    Get PDF
    Phorbol 12-myristate 13-acetate (PMA; a diacylglycerol mimetic) is known to augment polymorphonuclear leukocyte (PMN) superoxide (SO) release via protein kinase C (PKC) activation. However, the role of PKC beta II (βII) mediating this response is not known. It’s known that myristic acid (myr-) conjugation facilitates intracellular delivery of the cargo sequence, and that putative PKCβII activator and inhibitor peptides work by augmenting or attenuating PKCβII translocation to cell membrane substrates (e.g. NOX-2). Therefore, we hypothesize that myr- conjugated PKCβII peptide-activator (N-myr-SVEIWD; myr-PKCβ+) would increase PMA-induced rat PMN SO release, whereas, myr-PKCβII peptide-inhibitor (N-myr-SLNPEWNET; myr-PKCβ-) would attenuate this response compared to non-drug treated controls. Rat PMNs (5x106) were incubated for 15min at 370C in the presence/absence of myr-PKCβ+/- (20 μM) or SO dismutase (SOD;10μg/mL; n=8) as positive control. PMA (100nM) induced PMN SO release was measured spectrophotometrically at 550nm via reduction of ferricytochrome c for 390 sec. PMN SO release increased absorbance to 0.39±0.04 in non-drug treated controls (n=28), and 0.49±0.05 in myr-PKCβ+(n=16). This response was significantly increased from 180 seconds to 240 seconds (p\u3c0.05). By contrast, myr-PKCβ- (0.26±0.03; n=14) significantly attenuated PMA-induced SO release compared to non-drug controls and myr-PKCβ+ (p\u3c0.05). SOD-treated samples showed \u3e90% reduction of PMA-induced SO release and was significantly different from all groups (p\u3c0.01). Cell viability ranged between 94± to 98±2% in all groups as determined by 0.2% trypan blue exclusion. Preliminary results suggest that myr-PKCβ- significantly attenuates PMA-induced SO release, whereas myr-PKCβ+ significantly augments PMA-induced SO release, albeit transiently. Additional dose response and western blot experiments are planned with myr-PKCβ+/- in PMA-induced PMN SO release assays. This research was supported by the Department of Bio-Medical Sciences and the Division of Research at PCOM and by Young Therapeutics, LLC

    Protein Kinase C Beta II Peptide Inhibitor Elicits Robust Effects on Attenuating Myocardial Ischemia/Reperfusion Injury

    Get PDF
    Reperfusion injury contributes to myocardial tissue damage following a heart attack partly due to the generation of reactive oxygen species (ROS) upon cardio-angioplasty. Protein kinase C beta II (PKCβII) inhibition during reperfusion with peptide inhibitor (N-myr-SLNPEWNET; PKCβII-) decreases ROS release and leukocyte infiltration in rat hind-limb and myocardial ischemia/reperfusion (I/R) studies, respectively. However, the role of activating PKCβII during reperfusion has not been previously determined. In this study, we hypothesize that myristoylated (myr)-PKCβII- will decrease infarct size and improve post-reperfused cardiac function compared to untreated controls, whereas PKCβII peptide activator (N-myr-SVEIWD; myr-PKCβII+) will show no improvement compared to control. Myristoylation of PKCβII peptides facilitate their entry into the cell in order to affect PKCβII activity by either augmenting or attenuating its translocation to cell membrane proteins, such as NOX-2. Isolated perfused rat hearts were subjected to global I(30min)/R(50min) and infused with myr-PKCβII+ (20μM; n=9), myr-PKCβII- (20µM; n=8), or plasma (control; n=9) at reperfusion. Hearts were frozen (-20oC), sectioned and stained using 1% triphenyltetrazolium chloride to differentiate necrotic tissue. The measurement of Left ventricular (LV) cardiac function was determined using a pressure transducer and infarct size was calculated as percent dead tissue vs. total heart tissue weight. Myr-PKCβII- significantly improved LV end-diastolic pressure 37±7 mmHg compared to control (58±5; p\u3c0.01) and myr-PKCβII+ (58±4; p\u3c0.01). Myr-PKCβII- significantly reduced infarct size to 14±3% compared to control (26±5%; p\u3c0.01), while myr-PKCβII+ (25±3%) showed no difference. The data indicate that myr-PKCβII- may be a putative treatment to reduce myocardial reperfusion injury when given to heart attack patients during cardio-angioplasty. Future studies are planned to determine infarct size by Image J analysis

    Preserving and Using Germplasm and Dissociated Embryonic Cells for Conserving Caribbean and Pacific Coral

    Get PDF
    Coral reefs are experiencing unprecedented degradation due to human activities, and protecting specific reef habitats may not stop this decline, because the most serious threats are global (i.e., climate change), not local. However, ex situ preservation practices can provide safeguards for coral reef conservation. Specifically, modern advances in cryobiology and genome banking could secure existing species and genetic diversity until genotypes can be introduced into rehabilitated habitats. We assessed the feasibility of recovering viable sperm and embryonic cells post-thaw from two coral species, Acropora palmata and Fungia scutaria that have diffferent evolutionary histories, ecological niches and reproductive strategies. In vitro fertilization (IVF) of conspecific eggs using fresh (control) spermatozoa revealed high levels of fertilization (>90% in A. palmata; >84% in F. scutaria; P>0.05) that were unaffected by tested sperm concentrations. A solution of 10% dimethyl sulfoxide (DMSO) at cooling rates of 20 to 30°C/min most successfully cryopreserved both A. palmata and F. scutaria spermatozoa and allowed producing developing larvae in vitro. IVF success under these conditions was 65% in A. palmata and 53% in F. scutaria on particular nights; however, on subsequent nights, the same process resulted in little or no IVF success. Thus, the window for optimal freezing of high quality spermatozoa was short (∼5 h for one night each spawning cycle). Additionally, cryopreserved F. scutaria embryonic cells had∼50% post-thaw viability as measured by intact membranes. Thus, despite some differences between species, coral spermatozoa and embryonic cells are viable after low temperature (−196°C) storage, preservation and thawing. Based on these results, we have begun systematically banking coral spermatozoa and embryonic cells on a large-scale as a support approach for preserving existing bio- and genetic diversity found in reef systems

    Adult and larval forms of <i>A. palmata</i> and <i>F. scutaria</i>.

    No full text
    <p><b>A</b>) Adult and developing <i>A. palmata</i> larvae (inset) at the cornflake stage at ∼24 h. Scale bar = 50 µm. Adult photo by R. Williams, Smithsonian Institution. <b>B</b>) Adult and developing <i>F. scutaria</i> larvae at the swimming stage. Scale bar = 50 µm. Embryos that reached these stages were scored as successfully developed.</p

    Cryopreservation of coral sperm (all sperm exposed to freezing in these treatments).

    No full text
    <p><b>A</b>) <i>A. palmata</i> sperm were cryopreserved at cooling rates 20 to 30°C/min using 10% DMSO and PG, and IVF success was assessed and averaged over the single spawning period. This averaged graph revealed no difference between the two cryoprotectants and a mean fertilization success of ∼18%. <b>B</b>) However, if the <i>A. palmata</i> fertilization success during the spawning period was graphed by day, a 65% fertilization success occurred on Day 3 with 10% DMSO, whereas it was 25, 0 and 3% on Day 1, 2 and 4, respectively. For the first 3 nights, the control with fresh sperm held at ∼90%, then fell to 76% on the fourth evening. <b>C</b>) <i>F. scutaria</i> sperm were cryopreserved at rates 20 to 30°C/min using 10% DMSO versus PG, and fertilization success was assessed and averaged over two spawning periods (July and August 2010). Averaging indicated that 10% DMSO was the preferred cryoprotectant, and (as in <i>A. palmata</i>) there was no variability in time in terms of physiological responses during a spawning season. <b>D</b>) Variability in <i>F. scutaria</i> IVF success after cryopreservation over two nights of a single representative month (August 2010). Fresh sperm IVF success held steady at 65%, but sperm cryopreserved with 10% DMSO varied from 52 to 13% on the two evenings. Bars with the same letters were not different (<i>P</i>>0.05; ANOVA), whereas bars with different letters were different (<i>P</i><0.05; ANOVA).</p

    Embryonic <i>F. scutaria</i> cells after cryopreservation (all cells exposed to freezing in these treatments).

    No full text
    <p>Mean post-thaw viability of <i>F. scutaria</i> cells was ∼50% for all cryoprotectants tested. Ten thousand events were measured for each sample. Controls (the three left bars) were live-stained and unstained cells and 100% dead cells that produced control data for the flow cytometer (i.e., 100% intact versus 100% dead). Bars with the same letters were not different, whereas bars with different letters were different (P<0.05; Kruskal-Wallis test).</p
    corecore